Supernus Pharmaceuticals, Inc. (SUPN)
51.22
-0.08
(-0.17%)
USD |
NASDAQ |
Feb 10, 16:00
51.22
0.00 (0.00%)
After-Hours: 17:32
Supernus Pharmaceuticals Market Cap : 2.937B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.72B |
| Catalyst Pharmaceuticals, Inc. | 2.981B |
| Vertex Pharmaceuticals, Inc. | 117.60B |
| Krystal Biotech, Inc. | 7.839B |
| Moderna, Inc. | 16.41B |
Market Cap Related Metrics
| PS Ratio | 4.237 |
| Price to Book Value | 2.798 |
| Price to Free Cash Flow | 40.81 |
| Price | 51.22 |
| Earnings Yield | -0.67% |